Jeremy Orr, MD, of University of California, San Diego, has been awarded the new ATS [American Thoracic Society] Foundation/ResMed Research Fellowship in Noninvasive Ventilation (NIV) in COPD.

Orr’s $100,000 award will support his research focused on the impact of noninvasive ventilation on cardiovascular biomarkers in chronic obstructive pulmonary disease [COPD].

“Noninvasive ventilation during sleep is one of the few treatments in COPD that improves survival, but we don’t really understand the underlying mechanisms. This grant will facilitate my research into the potential systemic and extra-pulmonary benefits of NIV. As a junior physician-scientist, the impact of this foundation award on my career and research development is enormous,” Orr says in a release.

Carlos M. Nunez, MD, ResMed’s chief medical officer, says, “The more researchers learn about NIV’s effects on COPD, the more health care can effectively scale its efforts to improve patients’ disease management and quality of life. ResMed is proud to support ATS Foundation and Dr Orr’s investigation into this life-changing therapy.”